Life Science Leader
Michigan No Longer A Safe Haven For Pharmaceutical Companies?
April 17, 2024
Pharmaceutical companies may soon face more product liability litigation in Michigan after the state repealed its unique Drug Immunity Law. The Drug Immunity Law passed in 1995 provided an absolute defense for pharmaceutical companies in product liability suits stemming from the safety and efficacy of their drug products. Michigan reportedly had the only law in the nation that shielded drug manufacturers and sellers from such liability. This article addresses the impact of this change to Michigan’s law.
This article first appeared on Life Science Leader. View the article here.
Contacts
Capabilities
Suggested News & Insights
Sidley Wins a Trio of Awards at the 2026 Benchmark Litigation US AwardsMarch 12, 2026Generative AI and Privilege: Practical Lessons from Two Early Decisions and What Comes NextFebruary 27, 2026Sidley Represents Thermon in Its US$2.2 Billion Combination With CECO EnvironmentalFebruary 24, 2026Sidley Sponsors ICPHSO 2026 Annual MeetingMonday, February 23, 2026 – Thursday, February 26, 2026New Year, New Rule: A Fresh Framework for Multidistrict LitigationFebruary 19, 2026Sidley Maintains a Strong Presence at the 2026 Consumer Brands CPG Legal ForumWednesday, February 18, 2026 - Friday, February 20, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
